September 5, 2019 by Chain Drug Review
CVS Health, CVS-Aetna merger, U.S. District Judge Richard Leon
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON— A federal judge on Wednesday ruled in favor of a Justice Department settlement that allows CVS Health’s nearly $70 billion acquisition of health insurer Aetna. U.S. District Judge Richard Leon had spent a number of months questioning whether the settlement did enough to protect competition and consumers in health-care markets, raising the possibility that he
July 8, 2019 by Jeffrey Woldt
CVS, CVS-Aetna merger, Larry Merlo
July 8, 2019, Opinion, Uncategorized
Even as a misguided federal judge continues to review its merger with Aetna — a deal that was finalized last November — CVS Health is moving forward expeditiously to overhaul the health care delivery model. President and chief executive officer Larry Merlo and seven of his colleagues from the combined company’s management team recently laid
December 10, 2018 by Chain Drug Review
CVS, CVS Health, CVS-Aetna merger, Larry Merlo
Issue 12-10-2018, News
WOONSOCKET, R.I. — Just after the Thanksgiving weekend, CVS Health announced that it has completed its acquisition of Aetna, establishing CVS Health as the nation’s premier health innovation company. “Today marks the start of a new day in health care and a transformative moment for our company and our industry,” declared CVS Health president and
December 10, 2018 by Jeffrey Woldt
Aetna, CVS, CVS Health, CVS-Aetna merger
Issue 12-10-2018, Opinion
U.S. district court judge Richard Leon put somewhat of a damper on CVS Health’s merger with Aetna earlier this month when he indicated that he might order a halt to the integration of the companies, which finalized their $78 billion tie-up in late November after winning approval from the Department of Justice and state regulators.
November 28, 2018 by Chain Drug Review
CVS-Aetna merger, Larry Merlo
Videos
https://www.chaindrugreview.com/wp/app/uploads/2018/11/8433151_Interviews_Larry_1101.mp4
November 19, 2018 by Chain Drug Review
CVS, CVS-Aetna merger, Larry Merlo
Issue 11-19-2018, News
WOONSOCKET, R.I. — CVS Health will debut new concept stores early next year, said president and chief executive officer Larry Merlo. He said the company envisioned “a hub-and-spoke concept” with health hubs in a set number of outlets in a given market and the balance of the stores having core offerings that would serve as
September 24, 2018 by Chain Drug Review
CVS-Aetna merger
Issue 09-24-2018
WASHINGTON — CVS Health Corp.’s planned acquisition of Aetna Inc. is close to getting the go-ahead from federal regulators, The Wall Street Journal reported early this month. Antitrust regulators at the Department of Justice were also said to be close to signing off on another megadeal in the health care sector; insurer Cigna Corp.’s planned
July 9, 2018 by Chain Drug Review
CVS-Aetna merger, Larry Merlo
Issue 07-09-2018
WOONSOCKET, R.I. — With its $69 billion buyout of Aetna on track to close later this year, CVS Health announced the management team selected to lead the combined company. Assuming the deal passes muster with antitrust regulators, Aetna will operate as a stand-alone business unit within CVS Health and be led by members of its
May 14, 2018 by Jeffrey Woldt
CVS-Aetna merger, NACDS, Rite Aid, Walgreens
Issue 05-14-2018, Opinion
The National Association of Chain Drug Stores Annual Meeting last month in Palm Beach, Fla., unfolded against a backdrop of rapid-fire change in community pharmacy and the broader retailing and health care sectors. Leaders of many of the nation’s top mass market retailers, including discounters, supermarkets, dollar stores and even online merchants, as well as
April 17, 2018 by Chain Drug Review
CVS-Aetna merger
Issue 04-09-2018, News
WOONSOCKET, R.I. — CVS Health has moved a step closer to completing its acquisition of insurer Aetna Inc. after stockholders of both companies overwhelmingly approved the deal. The combination must still pass the scrutiny of regulators, however. More than 98% of CVS shares were voted in favor, while about 97% of Aetna shares voted to
March 19, 2018 by Chain Drug Review
B. Douglas Hoey, Cigna, Cigna-Express Scripts merger, CVS-Aetna merger, David Cordani, Express Scripts, Tim Wentworth
2018, Issue 03-19-2018, Issues, News
BLOOMFIELD, Conn. — Another blockbuster merger is adding momentum to the consolidation wave sweeping through the health care sector, and again crossing industry segments. Health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal. Under the agreement, unveiled earlier this month, Cigna will pay Express
March 13, 2018 by Chain Drug Review
Aetna, Amazon, Berskhire Hathaway, Cigna, CVS Health, CVS-Aetna merger, Express Scripts, JPMorgan Chase, Larry Merlo, Mark Bertolini, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Shareholders of CVS Health voted overwhelmingly to approve the company’s $69 billion deal to acquire health insurer Aetna Inc. CVS said that in a special stockholders meeting on Tuesday, more than 98% of shares were voted in favor of the CVS-Aetna merger agreement, which was announced in early December. Also at a
March 8, 2018 by Chain Drug Review
Aetna, Cigna, Cigna-Express Scripts merger, CVS Health, CVS-Aetna merger, David Cordani, Express Scripts, Tim Wentworth
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
BLOOMFIELD, Conn., and ST. LOUIS — Continuing cross-segment consolidation in the health care arena, health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal. The companies said Thursday that, under the Cigna-Express Scripts merger agreement, Cigna will pay Express Scripts shareholders $48.75 in cash and 0.2434
January 1, 2018 by Jeffrey Woldt and Chain Drug Review
Aetna, Affordable Care Act, CVS Health, CVS-Aetna merger, Jeffrey Woldt, Larry Merlo, Matthew Shay, National Retail Federation, Rite Aid, Tax Cuts and Jobs Act, Walgreens Boots Alliance
2018, Issue 01-01-2018, Issues, Opinion
A case could be made that for pharmacy operators passage of the Tax Cuts and Jobs Act late last month was the biggest story of 2017. Championed by the Republican leadership in Congress and President Trump, the $1.5 trillion measure will provide substantial, permanent tax relief for businesses — the corporate tax rate was cut